In recent years, the use of dermatology diagnostic devices has increased due to rising awareness of skin disorders such as the skin cancers, the increasing demand for better diagnosis, and technological advancements. The demand from the baby boomer generation is majorly driving the growth of this market.
Download PDF Brochure@ http://www.micromarketmonitor.com/contact/5149752788-download_pdf_brochure.html
The Asian market comprises China, Japan, India, Korea, Singapore, Malaysia, Indonesia, and the Rest of Asia. China holds the lion’s share of the Asian dermatology diagnostic devices market, mainly due to factors such as increasing skin disorders—the Chinese population is highly prone to skin melanoma.
Speak to Analyst @ http://www.micromarketmonitor.com/contact/5149752788-speak_to_analyst.html
The Japanese market is the second-largest market in Asia. This is expected to grow further due to increasing awareness of various skin ailments and the increasing number of skin cancer cases in the region.
The Indian market is anticipated to grow due to factors such as increase in insurance coverage, awareness on various skin disorders, and the demand for healthcare infrastructure. It is one of the fastest-growing markets in Asia in terms of CAGR.
In-depth profiling of key players have been conducted along with recent developments in the market (new product launches and partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their position in the Asian dermatology diagnostic devices market. Heine Optotechnik (Germany), Optomed Oy (Finland), FotoFinder Systems (Germany), Michelson Diagnostics (U.K.), GE Healthcare (U.K.), Philips Healthcare (Netherlands), Welch Allyn (U.S.), Carl Zeiss Meditec, Inc. (U.S.), Hitachi (Japan), Leica Microsystems (Germany), Olympus (Japan), Toshiba Medical Systems (Japan), and Siemens Healthcare (Germany) are some key players engaged in this market.